Search

Xuemei Xuemei Wang

from Palo Alto, CA
Age ~52
Get Report
Also known as:
Mei Wang Xue, I Wang
Phone and address:
530 University Ave, Palo Alto, CA 94301
Related to:
Amy E Wang, 76Fuxiu WangAmy Zhang, 62Shu Chen, 57Hsin-Fu Wang, 60
Connected to:
Adele R Wang, 107Aiyuan Wang, 52Akiet Wang, 74Alene P Wang, 52Amanda K Wang, 46Amei Wang, 61Amity H Wang, 70Amy Wang, 59Anastasia S Wang, 84Ange Wang, 34

Xuemei Wang Phones & Addresses

  • 530 University Ave, Palo Alto, CA 94301
  • 102 Albert Ave #4, East Lansing, MI 48823
  • 815 Cherry Ln #C, East Lansing, MI 48823
  • 40 Williams Ln, San Mateo, CA 94404
  • Foster City, CA
  • Daly City, CA

Publications

Us Patents

Stat Modulators

View page
US Patent:
6884782, Apr 26, 2005
Filed:
Nov 7, 2001
Appl. No.:
10/008244
Inventors:
Alan Huang - San Mateo CA, US
Jiwen Liu - Belmont CA, US
Julio Medina - San Carlos CA, US
Xuemei Wang - San Bruno CA, US
Feng Xu - Palo Alto CA, US
Liusheng Zhu - Burlingame CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07K005/06
US Classification:
514 19, 549200, 548535
Abstract:
The present invention provides compounds, compositions and methods for the inhibition or treatment of conditions or disorders modulated by the STAT transcription factors, particularly STAT4 and STAT6. Additionally, the compounds are useful for the diagnosis of conditions dependent on STAT signaling.

Ccr4 Antagonists

View page
US Patent:
7144903, Dec 5, 2006
Filed:
May 22, 2002
Appl. No.:
10/155605
Inventors:
Tassie Collins - San Mateo CA, US
Hossen Mahmud - San Antonio TX, US
Jonathan Houze - San Mateo CA, US
Alan Xi Huang - San Mateo CA, US
Julio C. Medina - San Carlos CA, US
Xuemei Wang - San Mateo CA, US
Feng Xu - Palo Alto CA, US
Qingge Xu - Burlingame CA, US
Liusheng Zhu - Burlingame CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 417/12
C07D 419/12
C07D 401/00
A61K 31/425
US Classification:
514365, 548181, 544137, 546209
Abstract:
Compounds, compositions and methods are provided that are useful in the treatment of chemokine receptor-mediated conditions and diseases. In particular, the invention provides compounds which modulate CCR4 function or a CCR4-mediated response. The subject compounds and compositions are useful for the treatment or prevention of inflammatory conditions and diseases.

Compounds And Methods Useful For Treating Asthma And Allergic Inflammation

View page
US Patent:
7960567, Jun 14, 2011
Filed:
Apr 30, 2008
Appl. No.:
12/113121
Inventors:
Matthew Brown - San Francisco CA, US
Michael G. Johnson - San Francisco CA, US
Jiwen Liu - Foster City CA, US
Sarah E. Lively - San Carlos CA, US
Julio C. Medina - San Carlos CA, US
Wang Shen - San Mateo CA, US
Xuemei Wang - Thousand Oaks CA, US
Yingcai Wang - Fremont CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 209/08
C07D 209/12
C07D 209/30
C07D 209/42
C07D 209/48
A61K 31/404
A61K 31/4035
US Classification:
548469, 548473, 548490, 514415, 514417
Abstract:
Compounds, compositions and methods that are useful in the treatment of inflammatory and immune-related diseases and conditions are provided herein. In particular, the invention provides compounds which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer. The subject compounds are carboxylic acid derivatives.

Modulation Of Ccr4 Function

View page
US Patent:
7262204, Aug 28, 2007
Filed:
Sep 2, 2003
Appl. No.:
10/654112
Inventors:
Tassie Collins - San Mateo CA, US
Daniel J. Dairaghi - Palo Alto CA, US
Hossen Mahmud - San Antonio TX, US
Brian E. McMaster - Mountain View CA, US
Julio C. Medina - San Carlos CA, US
Thomas J. Schall - Palo Alto CA, US
Feng Xu - Palo Alto CA, US
Xuemei Wang - San Mateo CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
ChemoCentryx, Inc. - Mountain View CA
International Classification:
A61K 31/47
A61K 31/425
A61K 31/385
US Classification:
514311, 514365, 514370, 514442
Abstract:
Compounds and compositions are provided that bind to the CCR4 chemokine receptor and which are useful for treating diseases associated with CCR4 activity, such as contact hypersensitivity.

Modulation Of Ccr4 Function

View page
US Patent:
20020173524, Nov 21, 2002
Filed:
Oct 11, 2001
Appl. No.:
09/975566
Inventors:
Tassie Collins - San Mateo CA, US
Daniel Dairaghi - Palo Alto CA, US
Hossen Mahmud - San Antonio TX, US
Brian McMaster - Mountain View CA, US
Julio Medina - San Carlos CA, US
Thomas Schall - Palo Alto CA, US
Feng Xu - Palo Alto CA, US
Xuemei Wang - San Mateo CA, US
Assignee:
Tularik Inc. - So. San Francisco CA
International Classification:
A61K031/426
A61K031/4245
A61K031/381
A61K031/36
A61K031/351
A61K031/265
A61K031/18
US Classification:
514/364000, 514/369000, 514/370000, 514/438000, 514/452000, 514/471000, 514/473000, 514/513000, 514/602000
Abstract:
Compounds and compositions are provided that bind to the CCR4 chemokine receptor and which are useful for treating diseases associated with CCR4 activity, such as contact hypersensitivity.

Stat Modulators

View page
US Patent:
20050101540, May 12, 2005
Filed:
Dec 14, 2004
Appl. No.:
11/014344
Inventors:
Alan Huang - San Mateo CA, US
Jiwen Liu - Belmont CA, US
Julio Medina - San Carlos CA, US
Xuemei Wang - San Bruno CA, US
Feng Xu - Palo Alto CA, US
Liusheng Zhu - Burlingame CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K038/04
G01N033/53
C07D487/02
US Classification:
514019000, 544184000, 544256000, 544280000, 435007100
Abstract:
The present invention provides compounds, compositions and methods for the inhibition or treatment of conditions or disorders modulated by the STAT transcription factors, particularly STAT4 and STAT6. Additionally, the compounds are useful for the diagnosis of conditions dependent on STAT signaling.

Isolation Of Pathogenic Prions

View page
US Patent:
20090099343, Apr 16, 2009
Filed:
Jan 13, 2006
Appl. No.:
11/795165
Inventors:
David Peretz - El Cerrito CA, US
Melissa Michelitsch - Berkeley CA, US
Celine Hu - Tiburon CA, US
David Chien - Alamo CA, US
John Hall - Emeryville CA, US
Xuemei Wang - Castro Valley CA, US
Man Gao - San Ramon CA, US
International Classification:
C07K 1/14
US Classification:
530412, 530418
Abstract:
Peptide reagents that interact preferentially with the PrPform of the prion protein are described. Methods of using the reagents for isolation and purification of the PrPisoform are described.

Elisa Assays Using Prion-Specific Peptide Reagents

View page
US Patent:
20090130774, May 21, 2009
Filed:
Jan 13, 2006
Appl. No.:
11/795163
Inventors:
David Peretz - El Cerrito CA, US
Melissa Michelitsch - Berkeley CA, US
Celine Hu - Tiburon CA, US
Xuemei Wang - Castro Valley CA, US
Man Gao - San Ramon CA, US
Michael Connolly - Hercules CA, US
Thomas Horn - Berkeley CA, US
Ronald Zuckermann - El Cerrito CA, US
David Chien - Alamo CA, US
International Classification:
G01N 33/566
US Classification:
436501
Abstract:
Peptide reagents that interact preferentially with the PrPsc form of the prion protein are described for use in detecting PrPsc in biological samples. In particular, ELISA assays are described.
Control profile
Xuemei Xuemei Wang from Palo Alto, CA, age ~52 Get Report